Skip to Content

LCI 1477 (Diethylpropion Hydrochloride Extended Release 75 mg)

Pill with imprint LCI 1477 is White, Capsule-shape and has been identified as Diethylpropion Hydrochloride Extended Release 75 mg. It is supplied by Lannett Company, Inc..

Diethylpropion is used in the treatment of obesity and belongs to the drug classes anorexiants, CNS stimulants. There is no proven risk in humans during pregnancy. Diethylpropion 75 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for LCI 1477

Diethylpropion Hydrochloride Extended Release

LCI 1477
75 mg
19.00 mm
Prescription only
Drug Class
Anorexiants, Cns stimulants
Pregnancy Category
B - No proven risk in humans
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Lannett Company, Inc.
National Drug Code (NDC)
Inactive Ingredients
mannitol, carbomer homopolymer type A, tartaric acid, hypromellose acetate succinate 06081224 (3 mm2/s), povidone k30, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.